IP Library Granted Patent US 8,697,688
Granted Patent B2
US 8,697,688 · App. 13/641,180 · Granted Apr 15, 2014

Pyrrolobenzodiazepines used to treat proliferative diseases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,697,688
App. No.
13/641,180
Granted
Apr 15, 2014
Kind
B2
Abstract

Pyrrolobenzodiazepine dimers I having a C2-C3 double bond and an aryl group at the C2 position on one monomer unit, and a C2-C3 double bond and either a conjugated double or triple bond at the C2 position or an alkyl group at the C2 position on the other monomer unit, and conjugates of these compounds.

Claims (29)

1. A compound with the formula I:

wherein:

R 2 is of formula III:

Where A is —C 6 H 4 —, X is NHR N , wherein R N is H, and Q 1 is a single bond, and Q 2 is a single bond;

R 12 is selected from:

(iia) methyl;

(iib) cyclopropyl;

(iic)

 wherein R 21 and R 22 are hydrogen and R 23 is methyl;

(iid)

 wherein R 25b is H and R 25a is phenyl; and

(iie)

 wherein R 24 is H;

R 6 and R 9 are H;

Where R is independently selected from optionally substituted C 1-12 alkyl, C 3-20 heterocyclyl and C 5-20 aryl groups;

R 7 is OH or OR;

R 10 and R 11 form a nitrogen-carbon double bond between the nitrogen and carbon atoms to which they are bound;

R″ os a C 3 alkylene group;

Y and Y′ are O;

R 6 , R 7 ′, R 9 ′ are selected from the same groups as R 6 , R 7 , and R 9 respectively and R 10 ′ and R 11 ′ are the same as R 10 and R 11 .

2. A compound according to claim 1 , with the structure:

3. A compound according to claim 1 , wherein R 12 is methyl.

4. A compound according to claim 1 , wherein R 12 is cyclopropyl.

5. A compound according to claim 1 , wherein R 12 is

and R 21 and R 22 are H and R 23 is methyl.

6. A compound according to claim 1 , wherein R 12 is

and R 25a is phenyl and R 25b is H.

7. A compound according to claim 1 , wherein R 12 is

and R 24 is H.

Assignments (7)
CHANGE OF NAME Recorded Feb 22, 2021
From: SEATTLE GENETICS, INC.
To: SEAGEN INC.
Reel/Frame 055362/0182 →
CORRECTIVE ASSIGNMENT TO CORRECT THE POSTAL CODE OF THE ASSIGNEE PREVIOUSLY RECORDED AT REEL: 036932 FRAME: 0278. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Apr 11, 2017
From: SPIROGEN SÀRL
To: MEDIMMUNE LIMITED
Reel/Frame 042242/0389 →
CONFIRMATORY ASSIGNMENT Recorded Oct 23, 2015
From: SPIROGEN SÀRL
To: MEDIMMUNE LIMITED
Reel/Frame 036932/0278 →
MERGER Recorded May 1, 2013
From: SPIROGEN DEVELOPMENTS SARL
To: SPIROGEN SARL
Reel/Frame 030326/0427 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2012
From: HOWARD, PHILIP WILSON; MASTERSON, LUKE; TIBERGHIEN, ARNAUD
To: SPIROGEN LIMITED
Reel/Frame 029370/0645 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2012
From: JEFFREY, SCOTT; BURKE, PATRICK; SENTER, PETER
To: SEATTLE GENETICS INC.
Reel/Frame 029370/0682 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2012
From: SPIROGEN LIMITED
To: SPIROGEN DEVELOPMENTS SARL
Reel/Frame 029370/0873 →